Neogen Deferred Long Term Liab vs Accounts Payable Analysis

NEOG Stock

USD 14.98 0.40 2.74%

Neogen financial indicator trend analysis is infinitely more than just investigating Neogen recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Neogen is a good investment. Please check the relationship between Neogen Deferred Long Term Liab and its Accounts Payable accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.

Deferred Long Term Liab vs Accounts Payable

Deferred Long Term Liab vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Neogen Deferred Long Term Liab account and Accounts Payable. At this time, the significance of the direction appears to have pay attention.

The correlation between Neogen's Deferred Long Term Liab and Accounts Payable is -0.71. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Neogen, assuming nothing else is changed. The correlation between historical values of Neogen's Deferred Long Term Liab and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Neogen are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Deferred Long Term Liab i.e., Neogen's Deferred Long Term Liab and Accounts Payable go up and down completely randomly.

Correlation Coefficient

-0.71

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Accounts Payable

An accounting item on the balance sheet that represents Neogen obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Neogen are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most indicators from Neogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Neogen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.At this time, Neogen's Enterprise Value is most likely to increase significantly in the upcoming years.

	2021	2022	2023	2024 (projected)
Gross Profit	243.0M	406.0M	463.9M	487.1M
Total Revenue	527.2M	822.4M	924.2M	970.4M

Gross Profit Total Revenue

Neogen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Common Stock Total Equity	Short Term Investments
Total Assets		0.84	0.93	0.98	1.0	0.96	0.84	0.69	0.11	1.0	-0.13	0.2	0.93	0.94	0.99	0.88	0.88	1.0	0.99	0.96	0.67	0.87	0.99	0.99	0.98	-0.22
Short Long Term Debt Total	0.84		0.89	0.9	0.85	0.84	0.96	0.7	0.25	0.82	-0.19	0.32	0.82	0.77	0.81	0.83	0.92	0.83	0.82	0.92	0.69	0.72	0.82	0.88	0.88	0.0
Other Current Liab	0.93	0.89		0.97	0.95	0.92	0.8	0.88	0.41	0.89	-0.09	0.51	0.96	0.9	0.88	0.94	0.96	0.9	0.89	0.94	0.86	0.7	0.89	0.96	0.95	0.11
Total Current Liabilities	0.98	0.9	0.97		0.99	0.98	0.85	0.8	0.27	0.96	-0.12	0.35	0.97	0.94	0.95	0.95	0.95	0.97	0.96	0.99	0.78	0.84	0.95	1.0	0.99	-0.07
Total Stockholder Equity	1.0	0.85	0.95	0.99		0.97	0.83	0.73	0.16	0.99	-0.12	0.26	0.95	0.94	0.98	0.91	0.9	0.99	0.99	0.97	0.71	0.86	0.99	0.99	0.98	-0.17
Property Plant And Equipment Net	0.96	0.84	0.92	0.98	0.97		0.8	0.77	0.25	0.94	-0.1	0.3	0.97	0.95	0.93	0.96	0.91	0.95	0.94	0.99	0.76	0.9	0.93	0.98	0.98	-0.12
Net Debt	0.84	0.96	0.8	0.85	0.83	0.8		0.51	-0.02	0.85	-0.18	0.06	0.73	0.74	0.85	0.72	0.83	0.84	0.85	0.88	0.48	0.77	0.85	0.85	0.83	-0.26
Retained Earnings	0.69	0.7	0.88	0.8	0.73	0.77	0.51		0.78	0.61	-0.08	0.83	0.88	0.73	0.58	0.9	0.86	0.63	0.6	0.76	1.0	0.44	0.6	0.76	0.78	0.52
Cash	0.11	0.25	0.41	0.27	0.16	0.25	-0.02	0.78		0.01	-0.08	0.98	0.41	0.19	-0.03	0.47	0.45	0.04	0.0	0.23	0.81	-0.1	0.0	0.22	0.26	0.92
Non Current Assets Total	1.0	0.82	0.89	0.96	0.99	0.94	0.85	0.61	0.01		-0.12	0.11	0.89	0.92	1.0	0.84	0.85	1.0	1.0	0.95	0.6	0.89	1.0	0.97	0.96	-0.31
Non Currrent Assets Other	-0.13	-0.19	-0.09	-0.12	-0.12	-0.1	-0.18	-0.08	-0.08	-0.12		-0.1	-0.04	-0.05	-0.13	-0.08	-0.23	-0.13	-0.13	-0.14	-0.1	-0.14	-0.12	-0.12	-0.15	-0.15
Cash And Short Term Investments	0.2	0.32	0.51	0.35	0.26	0.3	0.06	0.83	0.98	0.11	-0.1		0.47	0.26	0.07	0.51	0.52	0.13	0.09	0.29	0.85	-0.08	0.1	0.3	0.33	0.9
Net Receivables	0.93	0.82	0.96	0.97	0.95	0.97	0.73	0.88	0.41	0.89	-0.04	0.47		0.96	0.87	0.98	0.92	0.9	0.88	0.95	0.86	0.77	0.88	0.96	0.96	0.05
Common Stock Shares Outstanding	0.94	0.77	0.9	0.94	0.94	0.95	0.74	0.73	0.19	0.92	-0.05	0.26	0.96		0.91	0.92	0.84	0.93	0.92	0.93	0.72	0.86	0.91	0.95	0.94	-0.18
Non Current Liabilities Total	0.99	0.81	0.88	0.95	0.98	0.93	0.85	0.58	-0.03	1.0	-0.13	0.07	0.87	0.91		0.82	0.82	1.0	1.0	0.93	0.56	0.89	1.0	0.96	0.94	-0.35
Inventory	0.88	0.83	0.94	0.95	0.91	0.96	0.72	0.9	0.47	0.84	-0.08	0.51	0.98	0.92	0.82		0.93	0.85	0.83	0.95	0.89	0.78	0.83	0.94	0.94	0.12
Other Current Assets	0.88	0.92	0.96	0.95	0.9	0.91	0.83	0.86	0.45	0.85	-0.23	0.52	0.92	0.84	0.82	0.93		0.85	0.84	0.94	0.85	0.72	0.84	0.92	0.95	0.16
Other Stockholder Equity	1.0	0.83	0.9	0.97	0.99	0.95	0.84	0.63	0.04	1.0	-0.13	0.13	0.9	0.93	1.0	0.85	0.85		1.0	0.95	0.61	0.88	1.0	0.98	0.96	-0.29
Total Liab	0.99	0.82	0.89	0.96	0.99	0.94	0.85	0.6	0.0	1.0	-0.13	0.09	0.88	0.92	1.0	0.83	0.84	1.0		0.94	0.58	0.89	1.0	0.97	0.95	-0.32
Property Plant And Equipment Gross	0.96	0.92	0.94	0.99	0.97	0.99	0.88	0.76	0.23	0.95	-0.14	0.29	0.95	0.93	0.93	0.95	0.94	0.95	0.94		0.74	0.89	0.94	0.98	0.99	-0.11
Total Current Assets	0.67	0.69	0.86	0.78	0.71	0.76	0.48	1.0	0.81	0.6	-0.1	0.85	0.86	0.72	0.56	0.89	0.85	0.61	0.58	0.74		0.43	0.58	0.75	0.77	0.54
Short Term Debt	0.87	0.72	0.7	0.84	0.86	0.9	0.77	0.44	-0.1	0.89	-0.14	-0.08	0.77	0.86	0.89	0.78	0.72	0.88	0.89	0.89	0.43		0.87	0.86	0.86	-0.45
Intangible Assets	0.99	0.82	0.89	0.95	0.99	0.93	0.85	0.6	0.0	1.0	-0.12	0.1	0.88	0.91	1.0	0.83	0.84	1.0	1.0	0.94	0.58	0.87		0.97	0.95	-0.32
Accounts Payable	0.99	0.88	0.96	1.0	0.99	0.98	0.85	0.76	0.22	0.97	-0.12	0.3	0.96	0.95	0.96	0.94	0.92	0.98	0.97	0.98	0.75	0.86	0.97		0.99	-0.12
Common Stock Total Equity	0.98	0.88	0.95	0.99	0.98	0.98	0.83	0.78	0.26	0.96	-0.15	0.33	0.96	0.94	0.94	0.94	0.95	0.96	0.95	0.99	0.77	0.86	0.95	0.99		-0.08
Short Term Investments	-0.22	0.0	0.11	-0.07	-0.17	-0.12	-0.26	0.52	0.92	-0.31	-0.15	0.9	0.05	-0.18	-0.35	0.12	0.16	-0.29	-0.32	-0.11	0.54	-0.45	-0.32	-0.12	-0.08

Click cells to compare fundamentals

Neogen Account Relationship Matchups

Neogen fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	797.2M	920.2M	992.9M	4.6B	4.5B	4.8B
Other Current Liab	22.8M	26.6M	35.6M	57.2M	48.6M	51.1M
Total Current Liabilities	48.5M	53.6M	77.8M	145.5M	154.3M	162.0M
Total Stockholder Equity	725.2M	840.4M	887.4M	3.1B	3.1B	3.3B
Property Plant And Equipment Net	78.7M	100.5M	110.6M	198.7M	291.9M	306.5M
Net Debt	(342.6M)	(379.8M)	605.6M	736.8M	735.6M	772.4M
Retained Earnings	478.7M	539.6M	587.9M	565.0M	555.6M	583.4M
Cash	343.7M	381.1M	381.1M	163.2M	170.6M	179.1M
Non Current Assets Total	259.8M	328.7M	366.1M	4.0B	4.0B	4.2B
Non Currrent Assets Other	2.2M	2.0M	2.2M	15.2M	20.2M	15.7M
Cash And Short Term Investments	343.7M	381.1M	381.1M	245.6M	170.9M	179.5M
Net Receivables	84.7M	91.8M	99.7M	153.3M	173.0M	181.7M
Common Stock Shares Outstanding	105.7M	107.1M	108.0M	188.9M	216.5M	227.3M
Liabilities And Stockholders Equity	797.2M	920.2M	992.9M	4.6B	4.5B	4.8B
Non Current Liabilities Total	23.5M	26.2M	27.7M	1.3B	1.3B	1.3B
Inventory	95.1M	100.7M	122.3M	133.8M	189.3M	198.7M
Other Current Assets	14.0M	35.7M	47.5M	53.3M	56.0M	58.8M
Other Stockholder Equity	257.7M	295.0M	310.0M	2.6B	2.6B	2.7B
Total Liab	72.0M	79.8M	105.6M	1.4B	1.4B	1.5B
Property Plant And Equipment Gross	80.6M	102.9M	215.5M	318.9M	432.2M	453.8M
Total Current Assets	537.4M	591.5M	626.8M	585.9M	589.2M	618.7M
Accumulated Other Comprehensive Income	(19.7M)	(11.4M)	(27.8M)	(33.3M)	(30.0M)	(28.5M)
Intangible Assets	66.6M	92.3M	107.5M	1.6B	1.5B	1.6B
Accounts Payable	25.7M	23.9M	34.6M	76.7M	83.1M	87.2M
Common Stock Total Equity	8.5M	17.2M	17.2M	34.6M	39.8M	41.8M
Short Term Investments	277.4M	305.5M	336.6M	82.3M	325K	308.8K
Common Stock	8.5M	17.2M	17.2M	34.6M	34.7M	32.9M
Other Liab	22.6M	26.2M	27.7M	375.7M	432.1M	453.7M
Other Assets	2.2M	2.0M	4.8B	15.2M	1.0	0.95
Good Will	181.1M	228.3M	255.5M	3.8B	2.1B	2.2B
Property Plant Equipment	78.7M	100.5M	110.6M	198.7M	228.6M	240.0M
Net Tangible Assets	599.6M	612.1M	887.4M	3.1B	3.6B	3.8B
Retained Earnings Total Equity	478.7M	539.6M	587.9M	565.0M	649.8M	382.8M

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

When determining whether Neogen is a strong investment it is important to analyze Neogen's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neogen's future performance. For an informed investment choice regarding Neogen Stock, refer to the following important reports:

How To Invest In Neogen

Details

Is Neogen Stock a good investment?

Details

What is Neogen's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Neogen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

For more detail on how to invest in Neogen Stock please use our How to Invest in Neogen guide.

You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neogen. If investors know Neogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.86)

Earnings Share

(0.11)

Revenue Per Share

4.212

Quarterly Revenue Growth

(0.05)

Return On Assets

0.0085

The market value of Neogen is measured differently than its book value, which is the value of Neogen that is recorded on the company's balance sheet. Investors also form their own opinion of Neogen's value that differs from its market value or its book value, called intrinsic value, which is Neogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neogen's market value can be influenced by many factors that don't directly affect Neogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Neogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Neogen Deferred Long Term Liab vs Accounts Payable Analysis

Deferred Long Term Liab vs Accounts Payable

Deferred Long Term Liab vs Accounts Payable Correlation Analysis

Correlation Coefficient

Deferred Long Term Liab

Accounts Payable

Neogen fundamental ratios Correlations

Neogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Neogen fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Assets
Accounts Payable	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Retained Earnings
Non Current Liabilities Total	+ 1.0	Non Current Assets Total

Short Term Investments	- 0.45	Short Term Debt
Short Term Investments	- 0.35	Non Current Liabilities Total
Short Term Investments	- 0.32	Intangible Assets
Short Term Investments	- 0.32	Total Liab
Short Term Investments	- 0.31	Non Current Assets Total
Short Term Investments	- 0.29	Other Stockholder Equity